BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 18637152)

  • 21. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
    Luo J; Dunn TA; Ewing CM; Walsh PC; Isaacs WB
    Prostate; 2003 Oct; 57(2):134-9. PubMed ID: 12949937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells.
    Goossens K; Deboel L; Swinnen JV; Roskams T; Manin M; Rombauts W; Verhoeven G
    Prostate; 2002 Sep; 53(1):34-49. PubMed ID: 12210478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5alpha-reductase inhibitors/finasteride.
    Stoner E
    Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H; Igawa M; Ishibe T
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.
    Vignozzi L; Cellai I; Santi R; Lombardelli L; Morelli A; Comeglio P; Filippi S; Logiodice F; Carini M; Nesi G; Gacci M; Piccinni MP; Adorini L; Maggi M
    J Endocrinol; 2012 Jul; 214(1):31-43. PubMed ID: 22562653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.
    Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U
    Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES; Batchelor KW; Habib FK
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M; Chorzepa-Nowicka K; Wylot M; Piasecka M; Gaczarzewicz D
    Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
    Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
    J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of finasteride on prostate specific antigen: review of available data.
    Guess HA; Gormley GJ; Stoner E; Oesterling JE
    J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
    J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone regulation of human prostate in organ culture.
    Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
    Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
    Kusljic S; Exintaris B
    Prostate; 2010 Oct; 70(14):1555-62. PubMed ID: 20687229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
    Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
    Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.